Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-09-30 Sale | 2019-10-02 4:20 pm | Dova Pharmaceuticals Inc. | DOVA | Laliberte Kevin Sr. VP, Product Development | 3,696 | $28 | $103,488 | 4,761 (Direct) | View |
| 2019-09-25 Sale | 2019-09-27 4:05 pm | Dova Pharmaceuticals Inc. | DOVA | Laliberte Kevin Sr. VP, Product Development | 3,100 | $20 | $62,000 | 8,457 (Direct) | View |
| 2019-07-31 Sale | 2019-08-01 4:31 pm | Dova Pharmaceuticals Inc. | DOVA | Laliberte Kevin Sr. VP, Product Development | 1,389 | $15.97 | $22,182 | 21,557 (Direct) | View |
| 2019-07-01 Sale | 2019-07-02 4:57 pm | Dova Pharmaceuticals Inc. | DOVA | Laliberte Kevin Sr. VP, Product Development | 1,191 | $14.17 | $16,876 | 12,946 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2019-11-12 Disposition | 2019-11-12 4:37 pm | N/A 2027-03-27 | Dova Pharmaceuticals Inc. | DOVA | Laliberte Kevin Sr. VP, Product Development | 205,011 | $0 | 0 (Direct) | View |
| 2019-07-30 Option Award | 2019-08-01 4:31 pm | N/A 2029-07-30 | Dova Pharmaceuticals Inc. | DOVA | Laliberte Kevin Sr. VP, Product Development | 10,000 | $0 | 21,557 (Direct) | View |